The efficacy and safety of levofloxacin 750 mg (Hileflox) in the treatment of chronic prostatitis

Chronic prostatitis is the most common urological disease in men aged 20 to 50 years. Chronic bacterial prostatitis occurs in 5–10 % of cases.The aim of the study was to determine the efficacy and safety of Hileflox (levofloxacin) in chronic bacterial prostatitis in a dosage of 750 mg per day for 10...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: L. A. Logvinov, K. V. Kumachev, I. V. Vinogradov, L. M. Vinogradova, M. Yu. Gabliya, E. S. Dendeberov
Médium: Artigo
Jazyk:Russo
Vydáno: ABV-press 2014-11-01
Edice:Andrologiâ i Genitalʹnaâ Hirurgiâ
Témata:
chronic bacterial prostatitis
levofloxacin
antimicrobial treatment
On-line přístup:https://agx.abvpress.ru/jour/article/view/32
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky